SCHEDULE 13G: JPMorgan Chase & Co. Discloses Significant Passive Stake in DR Horton Inc.
Beneficial Ownership Disclosure
JPMorgan Chase & Co. has filed a Schedule 13G, reporting a 6.4% passive beneficial ownership stake in DR Horton Inc. as of December 31, 2024.
Summary
- JPMorgan Chase & Co. reported beneficial ownership of 20,789,218 shares of DR Horton Inc. Common Stock.
- This represents 6.4% of DR Horton Inc.'s outstanding common stock.
- The filing indicates that the shares are held in the ordinary course of business and not for the purpose of changing or influencing control of DR Horton Inc.
- JPMorgan Chase & Co. exercises sole voting power over 19,094,868 shares and sole dispositive power over 20,744,752 shares.
- Shared voting power is held over 214 shares, and shared dispositive power over 31,853 shares.
- The filing was made by JPMorgan Chase & Co. as a parent holding company or control person.
- Several subsidiaries of JPMorgan Chase & Co. are identified as having acquired the securities, including J.P. Morgan Trust Company of Delaware, J.P. Morgan Securities LLC, and JPMorgan Chase Bank, National Association, among others.
Sentiment
Score: 7
Explanation: The disclosure of a significant passive stake by a major financial institution like JPMorgan Chase & Co. in DR Horton Inc. is generally viewed positively as it signals institutional confidence in the company's long-term prospects and stability, without indicating any intent to influence control.
Positives
- A major financial institution, JPMorgan Chase & Co., holds a significant 6.4% stake in DR Horton Inc., indicating institutional confidence.
- The filing confirms the shares are held for investment purposes in the ordinary course of business, not for control, suggesting stability.
Future Outlook
NA
Industry Context
DR Horton Inc. is a prominent U.S. homebuilder. JPMorgan Chase & Co.'s significant passive stake suggests institutional interest in the housing sector, potentially reflecting a positive long-term view on the industry's stability or growth prospects, or as part of a diversified investment strategy.
Stakeholder Impact
- Shareholders: May view the significant institutional ownership as a positive signal of confidence in the company's value and stability.
- Investors: Provides transparency regarding major institutional holdings, which can influence investment decisions.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of event which requires filing of this statement (ownership threshold crossed). |
| 02/11/2025 | Date the Schedule 13G was signed and filed. |
Recommendation
holdKeywords
DR Horton Inc, JPMorgan Chase, Schedule 13G, beneficial ownership, common stock, institutional investor, homebuilder, financial services
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.